News View all news
Consumer group calls for FDA moratorium on opioid approvals
FDA should issue a moratorium on new opioid analgesic approvals, according to the advocacy group Public Citizen. In a letter to FDA Commissioner Scott Gottlieb and HHS Secretary Alex Azar, the group asserts that, along with the industry itself, "it is beyond question that the FDA is also culpable." The letter—signed by Sidney M.
FDA not objecting to losartan with NMBA below 9.82 ppm remaining on the market
FDA said Wednesday that it will temporarily allow certain manufacturers to sell losartan containing N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) above the interim acceptable intake limit of 0.96 parts per million (ppm) and below 9.82 ppm until the impurity can be eliminated.
New guidelines reverse long-standing recommendation to take aspirin for heart disease and stroke prevention
Taking a low-dose (75–100 mg) aspirin daily is no longer recommended for heart disease and stroke prevention among healthy older adults, according to the 2019 American College of Cardiology (ACC)/American Heart Association (AHA) Guideline on the Primary Prevention of Cardiovascular Disease, published on March 17.
March 15, 2019
Safety in the pharmacy: Continuing the dialogue
You may have noticed a resurgence recently of the online dialogue about the safety of pharmacists in the workplace, particularly after a pharmacist and technician were shot and wounded at their…0 comments
March 11, 2019
APhA Partners with iForumRx.org on New Line of Ambulatory Care Recertification Tools
The American Pharmacists Association (APhA) announced a partnership with iForumRx.org, an interactive web-based community for ambulatory care pharmacy specialists, to produce a new line of recertification tools centered around podcasts, panel discussions, and polls.
February 28, 2019
American and Canadian Pharmacist Associations Warn that Drug Importation Policies Could Put Patients at Risk
The American Pharmacists Association (APhA) and Canadian Pharmacists Association (CPhA) have issued a joint statement opposing U.S. federal legislation authorizing personal and commercial importation of prescription drugs from Canada.
APhA is the leading advocate for the pharmacy profession and a driving force in creating opportunities for pharmacists to play a key role in integrated patient care, and ensuring the profession is recognized as essential in optimal medication use. We strive to make your job as a pharmacist easier, by providing the latest industry news, continuing education and professional development opportunities, practice tools, and more, so that you can focus on caring for your patients.